| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 9 |
| 1 | PACLITAXEL (AIBUMIN-BOUND) | 9 |
| 2 | CARBOPLATIN | 7 |
| 3 | DURVALUMAB | 7 |
| 4 | TREMELIMUMAB | 6 |
| 5 | CISPLATIN | 3 |
| 6 | NIVOLUMAB | 3 |
| 7 | PEMBROLIZUMAB | 3 |
| 8 | AXITINIB | 2 |
| 9 | FLUOROURACIL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SILTUXIMAB | 1 | 0.0015 |
| 1 | TREMELIMUMAB | 6 | 0.0014 |
| 2 | EDARAVONE | 1 | 0.0006 |
| 3 | DURVALUMAB | 7 | 0.0003 |
| 4 | LEVOCARNITINE | 1 | 0.0003 |
| 5 | SILODOSIN | 1 | 0.0002 |
| 6 | RAMUCIRUMAB | 1 | 0.0002 |
| 7 | FONDAPARINUX SODIUM | 1 | 0.0001 |
| 8 | DUTASTERIDE | 1 | 0.0001 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 7 | 0.0003 |
| 2 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 8 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 7 | 0.0001 |
| 6 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 7 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 10 | 0.0000 |